Literature DB >> 32122644

Methods to study mechanisms underlying altered hepatic drug elimination during pregnancy.

Hyunyoung Jeong1, Catherine S Stika2.   

Abstract

Hepatic drug metabolism is a major route of drug elimination, mediated by multiple drug-metabolizing enzymes. Any changes in the rate and extent of hepatic drug metabolism can lead to altered drug efficacy or toxicity. Accumulating clinical evidence indicates that pregnancy is accompanied by changes in hepatic drug metabolism. In this article, we discuss in vitro and in vivo tools used to study the mechanisms underlying the altered drug metabolism during pregnancy, focusing on primary hepatocyte culture, transgenic animal models, and use of probe drugs to assess change in enzymatic activity. The information obtained from these studies has enabled prediction of clinical PK changes for a given drug in pregnant women.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hepatic drug metabolism; Hepatocytes; Pregnancy; Transgenic mice

Year:  2020        PMID: 32122644      PMCID: PMC7319048          DOI: 10.1016/j.semperi.2020.151228

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  36 in total

Review 1.  Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification.

Authors:  Jennifer E Sager; Jingjing Yu; Isabelle Ragueneau-Majlessi; Nina Isoherranen
Journal:  Drug Metab Dispos       Date:  2015-08-21       Impact factor: 3.922

Review 2.  Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.

Authors:  Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

3.  Steroid hormone levels in pregnancy and 1 year postpartum using isotope dilution tandem mass spectrometry.

Authors:  Offie P Soldin; Tiedong Guo; Elisabete Weiderpass; Rochelle E Tractenberg; Leena Hilakivi-Clarke; Steven J Soldin
Journal:  Fertil Steril       Date:  2005-09       Impact factor: 7.329

4.  A transgenic mouse model with a luciferase reporter for studying in vivo transcriptional regulation of the human CYP3A4 gene.

Authors:  Weisheng Zhang; Anthony F Purchio; Kevin Chen; Jianming Wu; Li Lu; Richard Coffee; Pamela R Contag; David B West
Journal:  Drug Metab Dispos       Date:  2003-08       Impact factor: 3.922

Review 5.  In vitro assays for induction of drug metabolism.

Authors:  Brian G Lake; Roger J Price; Amanda M Giddings; David G Walters
Journal:  Methods Mol Biol       Date:  2009

Review 6.  Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios.

Authors:  J Andrew Williams; Ruth Hyland; Barry C Jones; Dennis A Smith; Susan Hurst; Theunis C Goosen; Vincent Peterkin; Jeffrey R Koup; Simon E Ball
Journal:  Drug Metab Dispos       Date:  2004-08-10       Impact factor: 3.922

7.  Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria.

Authors:  Vincent M Isabella; Binh N Ha; Mary Joan Castillo; David J Lubkowicz; Sarah E Rowe; Yves A Millet; Cami L Anderson; Ning Li; Adam B Fisher; Kip A West; Philippa J Reeder; Munira M Momin; Christopher G Bergeron; Sarah E Guilmain; Paul F Miller; Caroline B Kurtz; Dean Falb
Journal:  Nat Biotechnol       Date:  2018-08-13       Impact factor: 54.908

Review 8.  Human hepatocytes in primary culture: the choice to investigate drug metabolism in man.

Authors:  M J Gómez-Lechón; M T Donato; J V Castell; R Jover
Journal:  Curr Drug Metab       Date:  2004-10       Impact factor: 3.731

9.  Isoform-specific regulation of cytochromes P450 expression by estradiol and progesterone.

Authors:  Su-Young Choi; Kwi Hye Koh; Hyunyoung Jeong
Journal:  Drug Metab Dispos       Date:  2012-07-26       Impact factor: 3.922

10.  Explanted diseased livers - a possible source of metabolic competent primary human hepatocytes.

Authors:  Moritz Kleine; Marc Riemer; Till Krech; Daphne DeTemple; Mark D Jäger; Frank Lehner; Michael P Manns; Jürgen Klempnauer; Jürgen Borlak; Hueseyin Bektas; Florian W R Vondran
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

View more
  3 in total

Review 1.  The Impact of Pregnancy on Antihypertensive Drug Metabolism and Pharmacokinetics: Current Status and Future Directions.

Authors:  Ian R Mulrenin; Julian E Garcia; Muluneh M Fashe; Matthew Shane Loop; Melissa A Daubert; Rachel Peragallo Urrutia; Craig R Lee
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-11       Impact factor: 4.481

2.  Evaluation of the Safety and Toxicity of the Original Copper Nanocomposite Based on Poly-N-vinylimidazole.

Authors:  Irina A Shurygina; Galina F Prozorova; Irina S Trukhan; Svetlana A Korzhova; Nataliya N Dremina; Artem I Emel'yanov; Olesya V Say; Nadezhda P Kuznetsova; Alexander S Pozdnyakov; Michael G Shurygin
Journal:  Nanomaterials (Basel)       Date:  2021-12-22       Impact factor: 5.076

3.  Impact of pregnancy related hormones on drug metabolizing enzyme and transport protein concentrations in human hepatocytes.

Authors:  Muluneh M Fashe; John K Fallon; Taryn A Miner; Jacqueline B Tiley; Philip C Smith; Craig R Lee
Journal:  Front Pharmacol       Date:  2022-09-21       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.